Dr. Reith R. Sarkar, MD

Dr. Sarkar practices at Valley Medical Center in Renton, Washington, part of University of Washington.

Dr. Sarkar's NPI, 1679034060, was assigned on March 27, 2019. Dr. Sarkar holds Washington license 61507146.

Dr. Sarkar's primary practice is Valley Medical Center, at 400 S 43rd St, Renton, WA 98055 in King County. The practice phone is (425) 228-3450.

Dr. Sarkar's primary practice is Valley Medical Center in Renton, Washington, part of University of Washington. Dr. Sarkar is also affiliated with Swedish First Hill Campus. The medical group on file is Tumor Institute Radiation Oncology Group (TIROG). Dmand AI also links Dr. Sarkar to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarkar practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sarkar's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sarkar is licensed in Washington.

CMS data shows 403 Medicare services from Dr. Sarkar across 10 procedure codes in 2024, for 42 Medicare patients. Medicare paid $31,047 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Sarkar in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarkar's median patient age at 70, with 33% women.

In 2024, Dr. Sarkar wrote 68 Medicare Part D claims for 47 patients. 79% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $45,633 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

Dr. Sarkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarkar as offering telehealth.

Dmand AI links 29 papers to Dr. Sarkar, published from 2018 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Cost-Benefit Analysis. Dr. Sarkar has published most often in Cancer. Dr. Sarkar's most frequent co-authors are James Don Murphy, MD, Brent Shane Rose, MD and Lucas Kas Vitzthum, MD.

CMS Open Payments shows 6 general payments to Dr. Sarkar from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.